FDA
- Status: approved
🇺🇸 JAKi dose reduction strategy in United States
JAKi dose reduction strategy (JAKi dose reduction strategy) regulatory status in United States.
Marketing authorisation
JAKi dose reduction strategy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is JAKi dose reduction strategy approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for JAKi dose reduction strategy in United States?
Sint Maartenskliniek is the originator. The local marketing authorisation holder may differ — check the official source linked above.